Common Contracts
6 similar Underwriting Agreement contracts by APRINOIA Therapeutics Inc., Maris Tech Ltd., Ebang International Holdings Inc., Republic Companies Group, Inc.
2,000,000 Shares APRINOIA Therapeutics Inc. Ordinary Shares of Par Value US$0.40 Per Share UNDERWRITING AGREEMENTUnderwriting Agreement • August 28th, 2024 • APRINOIA Therapeutics Inc. • Pharmaceutical preparations • New York
2,000,000 Shares APRINOIA Therapeutics Inc. Ordinary Shares of Par Value US$0.40 Per Share UNDERWRITING AGREEMENTUnderwriting Agreement • May 17th, 2024 • APRINOIA Therapeutics Inc. • Pharmaceutical preparations • New York
APRINOIA Therapeutics Inc., an exempted company with limited liability incorporated in the Cayman Islands (the “Company”), proposes, subject to the terms and conditions in this agreement (the “Agreement”), to issue and sell to the several underwriters listed in Schedule I hereto (collectively, the “Underwriters”) an aggregate of 2,000,000 ordinary shares (the “Ordinary Shares”) of par value $0.40 per share of the Company (such Ordinary Shares are hereinafter referred to as the “Firm Shares”). At the option of the Underwriters, the Company agrees, subject to the terms and conditions herein, to issue and sell to the Underwriters up to an aggregate of 300,000 additional Ordinary Shares (the “Option Shares”). The Firm Shares and the Option Shares, are herein referred to collectively as the “Shares.” The respective number of Shares to be purchased by each Underwriter is set forth opposite its name in Schedule I hereto.
Underwriting AgreementUnderwriting Agreement • December 6th, 2021 • Maris Tech Ltd. • Communications equipment, nec • New York
Underwriting AgreementUnderwriting Agreement • November 1st, 2021 • Maris Tech Ltd. • Communications equipment, nec • New York
Maris-Tech Ltd., an Israeli company (the “Company”), agrees, subject to the terms and conditions in this agreement (this “Agreement”), to issue and sell to the several underwriters listed in Schedule I hereto (collectively, the “Underwriters”) an aggregate of [●]ordinary shares (the “Firm Shares”), no par value per share, of the Company (the “Ordinary Shares”). At the option of the Underwriters, the Company agrees, subject to the terms and conditions herein, to issue and sell up to an aggregate of [●] additional Ordinary Shares representing fifteen percent (15.0%) of the total number of Firm Shares sold in the offering (the “Option Shares”). The Firm Shares and the Option Shares are herein referred to collectively as the “Securities”. The respective number of Units and Option Shares to be purchased by each Underwriter is set forth opposite its name in Schedule I hereto. Aegis Capital Corp. has agreed to act as the representative (the “Representative”) of the several Underwriters in con
UNDERWRITING AGREEMENTUnderwriting Agreement • June 17th, 2020 • Ebang International Holdings Inc. • Semiconductors & related devices • New York
Ebang International Holdings Inc., an exempted company with limited liability incorporated in the Cayman Islands. (the “Company”), proposes to sell 19,323,600 Class A ordinary shares (the “Firm Shares”), par value HK$0.001 per share of the Company (the “Ordinary Shares”) to the underwriters named on Schedule I (the “Underwriters”) attached to this agreement (this “Agreement”). In addition, the Company proposes to grant to the Underwriters an option to purchase up to an aggregate of 2,898,540 additional Ordinary Shares on the terms set forth in Section 2 (the “Option Shares”). The Firm Shares and the Option Shares, if purchased, are hereinafter collectively called the “Shares.” This Agreement is to confirm the agreement concerning the purchase of the Shares from the Company by the Underwriters.
6,000,000 SHARES REPUBLIC COMPANIES GROUP, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • July 19th, 2005 • Republic Companies Group, Inc. • Fire, marine & casualty insurance • New York
Republic Companies Group, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 6,000,000 shares of common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 900,000 shares of common stock, par value $0.01 per share, of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of common stock, par value $0.01 per share, of the Company to be outstanding after giving effect to the sale of the Shares and to the conversion of securities of the Company into such shares as described in the Prospectus (as defined below) are herein referred to as the “Common Stock.”
